Related Experiment Videos
[Mesangiocapillary glomerulonephritis]
Abstract:
Mesangiocapillary glomerulonephritis (MCGN) accounting for 15 percent of adult glomerulopathy has not received proper attention in the Hungarian medical literature. The present study offers a detailed description of the procedures to be used for distinguishing its three types, which is only possible by histological, mainly electron microscopic examination of kidney biopsy samples. Type I represents subendothelial deposits; Type II is the "sausage-like" dense deposits localised on the lamina densa of the glomerular basal basement membrane; Type III is the mixed type. There is no significant difference in their clinical appearance. They occur most frequently as "coloured nephrosis" (the syndrome of nephrosis is associated with haematuria and/or hypertension). The course of the disease is characterised by periodicity, and in 50 percent of the cases kidney failure may develop. The therapy for MCGN has not been established. The administration of steroid, cyclophosphamide and anticoagulant can have a favourable effect.
Insights
Mesangiocapillary glomerulonephritis (MCGN) is a kidney disease affecting 15% of adults. Distinguishing its three types requires kidney biopsy examination, as clinical presentation is similar, but prognosis varies.
Area of Science:
- Nephrology
- Pathology
- Histology
Context:
- Mesangiocapillary glomerulonephritis (MCGN) represents 15% of adult glomerulopathy.
- Limited attention in Hungarian medical literature necessitates detailed diagnostic guidance.
- MCGN presents clinically as "colored nephrosis" with hematuria and/or hypertension.
Purpose:
- To detail histological procedures for differentiating the three types of MCGN.
- To emphasize the crucial role of electron microscopy in accurate classification.
- To provide a comprehensive overview of MCGN diagnosis and management.
Summary:
- MCGN Type I: subendothelial deposits.
- MCGN Type II: dense "sausage-like" deposits on the glomerular basal basement membrane.
- MCGN Type III: mixed deposit patterns.
- Clinical presentation is uniform across types, often manifesting as nephrotic syndrome with hematuria/hypertension.
- Disease progression can lead to kidney failure in 50% of cases.
- Therapeutic strategies for MCGN remain unestablished, though steroids, cyclophosphamide, and anticoagulants may offer benefits.
Impact:
- Enhances diagnostic accuracy for MCGN through detailed histological criteria.
- Improves understanding of MCGN subtypes, crucial for potential targeted therapies.
- Highlights the need for further research into effective MCGN treatments.